Compare IH & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IH | PMVP |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 59.1M |
| IPO Year | 2020 | 2020 |
| Metric | IH | PMVP |
|---|---|---|
| Price | $2.05 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 17.9K | ★ 301.3K |
| Earning Date | 03-24-2026 | 03-02-2026 |
| Dividend Yield | ★ 4.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $119,261,855.00 | N/A |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.76 | $0.81 |
| 52 Week High | $3.60 | $1.84 |
| Indicator | IH | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 47.31 |
| Support Level | $1.95 | $1.08 |
| Resistance Level | $2.24 | $1.25 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 59.14 | 37.78 |
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.